ZNF703 inhibitors belong to a distinct class of chemical compounds designed to target and modulate the activity of ZNF703, which stands for Zinc Finger Protein 703. ZNF703 is a transcription factor, and transcription factors are crucial regulators of gene expression in cells, orchestrating the activation or repression of specific genes in response to various signals and cellular contexts. ZNF703, in particular, has garnered attention due to its potential involvement in a range of cellular processes, including cell growth, proliferation, and differentiation. Inhibitors of ZNF703 are developed with the aim of interacting with this protein, potentially influencing its binding to DNA sequences, its interactions with co-regulatory proteins, or its ability to modulate gene expression, thereby affecting the transcriptional programs it controls.
Structurally, ZNF703 inhibitors are meticulously designed to engage specific regions or binding sites on the ZNF703 protein. By doing so, they may disrupt the normal functioning of ZNF703 as a transcription factor, potentially leading to alterations in the expression patterns of genes under its control. The precise mechanisms by which ZNF703 inhibitors exert their effects can vary, but their overarching goal is to serve as a valuable tool for researchers studying the regulatory networks governed by ZNF703 in various cellular contexts. Investigating the molecular interactions and functional consequences of inhibiting ZNF703 can contribute to a deeper understanding of gene regulation, cellular responses to environmental cues, and the broader field of molecular biology, offering insights into the intricate mechanisms that govern fundamental cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Tamoxifen | 10540-29-1 | sc-208414 | 2.5 g | $272.00 | 18 | |
Tamoxifen is a selective estrogen receptor modulator (SERM). Given the association of ZNF703 tamoxifen may influence its expression. | ||||||
Letrozole | 112809-51-5 | sc-204791 sc-204791A | 25 mg 50 mg | $87.00 $147.00 | 5 | |
Letrozole, an aromatase inhibitor, might influence ZNF703 expression indirectly via estrogen modulation in breast cancer. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor could alter the methylation status of the ZNF703 promoter, potentially affecting its expression. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
As an HDAC inhibitor, trichostatin A can change chromatin structure and may influence ZNF703 transcription. | ||||||
Ribociclib | 1211441-98-3 | sc-507367 | 10 mg | $450.00 | ||
Another CDK4/6 inhibitor, ribociclib might indirectly modulate ZNF703 expression in specific cellular environments. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
Gefitinib, an EGFR inhibitor, affects multiple downstream signaling pathways and may have indirect effects on ZNF703 expression. | ||||||
Lapatinib | 231277-92-2 | sc-353658 | 100 mg | $420.00 | 32 | |
As an inhibitor of HER2/neu and EGFR, lapatinib might indirectly influence ZNF703 expression in HER2+ breast cancers. | ||||||
Everolimus | 159351-69-6 | sc-218452 sc-218452A | 5 mg 50 mg | $131.00 $651.00 | 7 | |
By inhibiting mTOR, everolimus can influence various cellular processes, potentially affecting ZNF703 expression indirectly. | ||||||
Bicalutamide | 90357-06-5 | sc-202976 sc-202976A | 100 mg 500 mg | $42.00 $146.00 | 27 | |
This androgen receptor antagonist might have indirect effects on ZNF703 expression in specific cell types or conditions. | ||||||
Temozolomide | 85622-93-1 | sc-203292 sc-203292A | 25 mg 100 mg | $91.00 $255.00 | 32 | |
As an alkylating agent, temozolomide might influence DNA damage responses and indirectly modulate ZNF703 expression. | ||||||